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Background
Skeletal muscle constitutes approximately 40% of body
mass, and age-induced decrease of muscle strength
impinge on daily activities and on normal social life in
the elderly. Loss of muscle strength has been recognised
as a debilitating and life threatening condition also in
cachexia in cancer patients and in clinical conditions
associated with prolonged bed rest. Skeletal muscle
dihydropyridine receptors (Cav1.1) act as Ca2+ channels
and voltage sensors to initiate muscle contraction by
activating ryanodine receptors, the Ca2+ release chan-
nels of the sarcoplasmic reticulum. Cav1.1 activity is
enhanced by a retrograde stimulatory signal delivered by
the ryanodine receptor. JP45 is a membrane protein
interacting with Cav1.1 and the sarcoplasmic reticulum
Ca2+ storage protein calsequestrin (CASQ1).
We hypothesized that JP45 and CASQ1 form a signal-
ling pathway which modulates Cav1.1 channel activity.
Materials and methods
We isolated flexor digitorum brevis (FDB) muscle fibres
from JP45 and CASQ1 double knock-out mice (DKO)
and tested whether there were differences in Ca2+
homeostasis between the different mouse lines.
Results
Our results show that Ca2+ transients evoked by tetanic
stimulation in DKO fibres, result from massive Ca2+
influx due to enhanced Cav1.1 channel activity. This
enhanced activity causes an increase of muscle strength
both in vitro and in vivo.
Conclusions
We conclude that skeletal muscle contraction is
strengthened through the modulation of Cav1.1 channel
activity by JP45 and CASQ1.
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